| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | -0.029 | 0.6 |
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | WAY-362450 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | AM-580 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | IC-87114 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | selumetinib:UNC0638 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | ISOX | CTRPv2 | pan-cancer | AAC | -0.016 | 0.6 |